These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32274652)

  • 21. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
    Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
    Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
    Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
    Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An overview of the research of cancer-related cognitive impairment].
    Ferencz V; S Nagy Z; Tóth M
    Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Analysis of the Chemotherapy-Related Cognitive Impairments in Patients with Breast Cancer: A Community-Based Research.
    Owrangi M; Gholamzadeh MJ; Vasaghi Gharamaleki M; Mousavi SZ; Kamali AM; Dehghani M; Chakrabarti P; Nami M
    Cancer Invest; 2022 Oct; 40(9):811-821. PubMed ID: 35880822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.
    Vardy J; Wefel JS; Ahles T; Tannock IF; Schagen SB
    Ann Oncol; 2008 Apr; 19(4):623-9. PubMed ID: 17974553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.
    Wang L; Apple AC; Schroeder MP; Ryals AJ; Voss JL; Gitelman D; Sweet JJ; Butt ZA; Cella D; Wagner LI
    Cancer; 2016 Jan; 122(2):258-68. PubMed ID: 26484435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.
    Reid-Arndt SA; Yee A; Perry MC; Hsieh C
    J Psychosoc Oncol; 2009; 27(4):415-34. PubMed ID: 19813133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.
    Deprez S; Vandenbulcke M; Peeters R; Emsell L; Smeets A; Christiaens MR; Amant F; Sunaert S
    J Clin Oncol; 2014 Jul; 32(19):2031-8. PubMed ID: 24868029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
    Alvarez J; Meyer FL; Granoff DL; Lundy A
    Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
    Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
    Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Ng T; Phey XY; Yeo HL; Shwe M; Gan YX; Ng R; Ho HK; Chan A
    Clin Breast Cancer; 2018 Oct; 18(5):e927-e937. PubMed ID: 29705024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.
    Deprez S; Amant F; Smeets A; Peeters R; Leemans A; Van Hecke W; Verhoeven JS; Christiaens MR; Vandenberghe J; Vandenbulcke M; Sunaert S
    J Clin Oncol; 2012 Jan; 30(3):274-81. PubMed ID: 22184379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.
    Deprez S; Amant F; Yigit R; Porke K; Verhoeven J; Van den Stock J; Smeets A; Christiaens MR; Leemans A; Van Hecke W; Vandenberghe J; Vandenbulcke M; Sunaert S
    Hum Brain Mapp; 2011 Mar; 32(3):480-93. PubMed ID: 20725909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mixed-methods study of cognitive performance in persons with multiple sclerosis: Association between neuropsychological test performance and interviews about daily cognitive functioning.
    Akbar N; Finlayson M
    Mult Scler Relat Disord; 2021 Jul; 52():102911. PubMed ID: 34111681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study.
    Huisman J; Aukema EJ; Deijen JB; van Coeverden SC; Kaspers GJ; van der Pal HJ; Delemarre-van de Waal HA
    BMC Pediatr; 2008 Jun; 8():25. PubMed ID: 18570650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options.
    Di Iulio F; Cravello L; Shofany J; Paolucci S; Caltagirone C; Morone G
    Neurol Sci; 2019 Sep; 40(9):1759-1774. PubMed ID: 31049790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of cognitive decline in people with cancer undergoing chemotherapy.
    Oh PJ
    Eur J Oncol Nurs; 2017 Apr; 27():53-59. PubMed ID: 28027862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.